Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis
Background. The guidelines on antithrombotic treatment in patients with symptomatic peripheral artery disease (PAD) undergoing peripheral revascularization of the lower extremities were developed based on heterogeneous trials, assessing various dose regimens and recruiting patients who were subjecte...
Main Authors: | Rupert Bauersachs, Olivia Wu, Neil Hawkins, Kevin Bowrin, Piotr Wojciechowski, Emilie Clay, Maria Huelsebeck |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi-Wiley
2021-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2021/8561350 |
Similar Items
-
Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review
by: Rupert Bauersachs, et al.
Published: (2019-01-01) -
Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials
by: Rupert Bauersachs, et al.
Published: (2020-01-01) -
Peripheral nerve regeneration and intraneural revascularization
by: Martial Caillaud, et al.
Published: (2019-01-01) -
The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization
by: Serra R, et al.
Published: (2021-07-01) -
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
by: Rupert Bauersachs, et al.
Published: (2020-05-01)